Atlas Trials

Immunogenicity of 9-valent HPV Vaccine

Clinical trial NCT05439083 · UNKNOWN

Trial details

NCT number
NCT05439083
Sponsor
Talia Sainz Costa
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Human Papilloma Virus Infection
Start date
2023-03-07
Primary completion
2024-09-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.